Search Results - A. Londhe

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Community awareness initiative about antimicrobial resistance: An educational intervention by medical undergraduates by Bhagyashri D. Rajopadhye, Vasundhara A. Londhe, Nivedita A. Pingle, Priti P. Dhande

    Published in Journal of Education and Health Promotion (2024-08-01)
    Get full text
    Article


  2. 2

    Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospecti... by Ajit A Londhe, Chantal E Holy, James Weaver, Sergio Fonseca, Angelina Villasis, Daniel Fife

    Published in PLoS ONE (2021-01-01)
    Get full text
    Article


  3. 3

    Risk of retinal detachment and exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of thr... by Ajit A Londhe, Chantal E Holy, James Weaver, Sergio Fonseca, Angelina Villasis-Keever, Daniel Fife

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  4. 4

    PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA by A. Krishnan, A. K. Nooka, A. Chari, A. Garfall, T. Martin, S. Nair, X. Lin, K. Qi, A. Londhe, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, S. Usmani

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P972: INDIRECT COMPARISON OF TECLISTIMAB IN MAJESTEC-1 VERSUS PHYSICIAN’S CHOICE OF THERAPY IN LONG-TERM FOLLOW-UP OF TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA IN D... by K. Weisel, A. Chari, S. Z. Usmani, H. Goldschmidt, M.-V. Mateos, K. Qi, A. Londhe, S. Nair, X. Lin, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, P. Moreau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES... by H. Einsele, B. Dhakal, J. M. Schecter, T. Roccia, W. Deraedt, N. Lendvai, A. Slaughter, C. Lonardi, K. Connors, K. Qi, A. Londhe, R. Carson, J. Voelker, P. Cost, S. Valluri, E. Florendo, L. Pacaud, K. Yong

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  7. 7

    P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMP... by M. Delforge, S. Z. Usmani, N. W. van de Donk, A. L. Garfall, P. Moreau, A. Oriol, A. K. Nooka, L. Rosinol, N. Bahlis, P. Rodriguez-Otero, T. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, A. Krishnan

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  8. 8

    PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON by L. Rosinol, S. Z. Usmani, N. Bahlis, A. Y. Krishnan, A. K. Nooka, A. Oriol, M. Delforge, A. L. Garfall, N. W. van de Donk, P. Rodríguez Otero, T. G. Martin, J. Diels, S. Van Sanden, L. Pei, E. Ammann, R. Kobos, M. Slavcev, J. Smit, A. Londhe, P. Moreau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study by Jie Zhang, Peter Yu, Sudhakar Manne, Ying Bao, Cathy W Critchlow, Julia Zhu, Zhongyuan Wei, Manasi Suryavanshi, Xiu Chen, Qian Xia, Jenny Jiang, Olulade Ayodele, Brian D Bradbury, Corinne Brooks, Carolyn A Brown, Alvan Cheng, Giovanna Devercelli, Vivek Gandhi, Kathleen Gondek, Ajit A Londhe, Junjie Ma, Michele Jonsson-Funk, Hillary A Keenan, Kaili Ren, Lynn Sanders, Linyun Zhou

    Published in BMJ Open (2021-08-01)
    Get full text
    Article


Search Tools: